Professor Gordon Dougan
Gordon Dougan is a Senior Group Leader at the Wellcome Trust Sanger Institute and the GSK Professor of Microbial Pathogenesis at the University of Cambridge in the Department of Medicine. His research focuses on the genetic (genomic) analysis of host-pathogen interactions during infection, particularly those involving enteric bacteria. He is an expert on typhoid.
He has worked extensively in both academia and industry, making important contributions in the field of vaccinology where he has worked to improve vaccine delivery to poorly resourced regions. He worked for more than ten years for the multi-national pharmaceutical company, The Wellcome Foundation, which is now part of GSK. During this period he became Head of Molecular Biology, managing teams working on vaccines, humanised antibodies and scale-up systems. He contributed to the discovery of pertactin as a key protective antigen for acellular whooping cough vaccines.
Gordon is a Fellow of the Royal Society, the Biology Society, the Academy of Medical Sciences and is an EMBO (European Molecular Biology Organization) member. He established the Centre for Molecular Microbiology and Infection (including raising funding for a building) at Imperial College London and was the Board of Management representative for Pathogen Research for ten years (2004-2014) at the Sanger Institute. He is an advisor for many companies, serving as a Scientific Advisory Board (SAB) or Board member. Gordon was Chair of the SAB for Novartis Vaccines & Diagnostics for more than ten years and helped found the Novartis Vaccine Global Health Institute (NVGH). He is currently on the board of The Hilleman Laboratories, a joint enterprise between Merck and The Wellcome Trust and has founded spin-out companies and served as a Trustee at the International Vaccine Institute in Korea. Gordon is also currently an SAB member for ICDDR-B (International Centre for Diarrhoeal Disease Research, Bangladesh). He holds adjunct professorships at Monash and Melbourne University and is an Honorary Professor at the London School of Hygiene and Tropical Medicine, where he sits on the Strategic Advisory Committee. He is a founder of the companies VHSquared and Microbiotica.
Dr. Elizabeth Klemm PhD
Elizabeth Klemm is a postdoctoral fellow at the Wellcome Trust Sanger Institute. Her research interests centre around host-pathogen interactions as they relate to global health and infectious disease. Integrating genomics tools and laboratory-based techniques, she has led studies on antimicrobial resistance, within-host evolution, and pathogen immune evasion. Her work has enabled a better undertanding of host adaptation in emerging infectious diseases. She obtained her PhD at MIT.
Dr. Vanessa Wong PhD
Vanessa Wong is a clinical Lecturer in Microbiology and Infectious Diseases at the University of Cambridge and an Honorary Speciality Registrar in Microbiology and Infectious Diseases at Addenbrooke’s Hospital. Her research interests include pathogen genomics and host-pathogen interactions in infection. She undertook her medical degree at Oxford and has trained in Nottingham, London and Cambridge. During training she was also awarded a PhD from the University of Cambridge for her work on the global surveillance of typhoid fever based on genomics. This work formed the basis of a Clinical Research Fellowship to develop a simple genotyping scheme that can be used by laboratories to track typhoid transmission in the field.